Safety and efficacy of high-dose leukocytapheresis in patients with refractory asthma
Objective and design
An open-label, non-randomized, single-arm study was performed to investigate the safety and efficacy of high-dose leukocytapheresis (pulse LCAP) for refractory asthma.
Six patients who fulfilled the ATS workshop criteria for refractory asthma were enrolled and completed this clinical study.
After 4 weeks of observation, pulse LCAP using a large LCAP filter, Cellsorba® CS-180S, was performed twice with a 1-week interval at a target dose of 5 L per treatment session.
The clinical response was assessed by monitoring the peak expiratory flow rate (PEFR) twice a day. The asthma control test (ACT) was used to evaluate the condition of asthma symptoms. The fraction of exhaled nitric oxide (FeNO) as a biomarker for eosinophilic airway inflammation was measured using a chemiluminescence analyzer.
PEFR in the morning or the evening and the sum total of the score on the ACT were increased after two consecutive sessions of pulse LCAP. FeNO decreased after pulse LCAP.
The results suggest the efficacy of pulse LCAP for refractory asthma.
KeywordsRefractory asthma Leukocytapheresis (LCAP) Peak expiratory flow rate (PEFR) Asthma control test (ACT) Fraction of exhaled nitric oxide (FeNO)
This work was partly supported by Health and Labour Science Research Grants (main investigator: Takahiro Tsuburai, M.D.).
- 6.Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J, et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy. 2005;60:309–16.PubMedCrossRefGoogle Scholar
- 11.Sakuraba A, Motoya S, Watanabe K, Nishishita M, Kanke K, Matsui T, et al. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment. Am J Gastroenterol. 2009;104:2990–5.PubMedCrossRefGoogle Scholar
- 13.Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med. 2000; 162: 2341–51.Google Scholar
- 19.ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005; 171: 912–30.Google Scholar
- 26.Hidaka T, Suzuki K, Matsuki Y, Takamizawa-Matsumoto M, Okada M, Ishizuka T, et al. Changes in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. Ther Apher. 1999;3:178–85.PubMedCrossRefGoogle Scholar
- 30.Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Kikuyama M, et al. Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis. World J Gastroenterol. 2005;11:3085–90.PubMedGoogle Scholar